MUCCI, Armida
 Distribuzione geografica
Continente #
EU - Europa 22.206
NA - Nord America 13.222
AS - Asia 8.835
SA - Sud America 1.227
Continente sconosciuto - Info sul continente non disponibili 735
AF - Africa 97
OC - Oceania 30
AN - Antartide 1
Totale 46.353
Nazione #
US - Stati Uniti d'America 12.962
RU - Federazione Russa 12.347
IT - Italia 3.430
SG - Singapore 3.291
IE - Irlanda 2.133
CN - Cina 1.582
HK - Hong Kong 1.450
UA - Ucraina 1.074
BR - Brasile 1.038
GB - Regno Unito 927
VN - Vietnam 880
DE - Germania 638
FR - Francia 464
JP - Giappone 413
KR - Corea 360
FI - Finlandia 302
SE - Svezia 286
TR - Turchia 282
IN - India 257
GR - Grecia 235
CA - Canada 120
NL - Olanda 115
BD - Bangladesh 75
AR - Argentina 71
ES - Italia 64
MX - Messico 55
IQ - Iraq 40
AT - Austria 34
PL - Polonia 31
BE - Belgio 30
ID - Indonesia 29
AU - Australia 27
CO - Colombia 27
EC - Ecuador 27
ZA - Sudafrica 24
PK - Pakistan 23
MA - Marocco 19
SA - Arabia Saudita 19
CR - Costa Rica 18
VE - Venezuela 18
CH - Svizzera 17
TW - Taiwan 17
UZ - Uzbekistan 17
CZ - Repubblica Ceca 14
EG - Egitto 13
EU - Europa 12
CL - Cile 11
JM - Giamaica 11
NP - Nepal 11
NO - Norvegia 10
PE - Perù 10
PY - Paraguay 10
RO - Romania 10
MY - Malesia 9
NI - Nicaragua 9
UY - Uruguay 9
AE - Emirati Arabi Uniti 8
JO - Giordania 8
KE - Kenya 8
TH - Thailandia 8
TT - Trinidad e Tobago 8
AL - Albania 7
GT - Guatemala 7
PT - Portogallo 7
AZ - Azerbaigian 6
DK - Danimarca 6
ET - Etiopia 6
IL - Israele 6
IR - Iran 6
PH - Filippine 6
SN - Senegal 6
TN - Tunisia 6
BO - Bolivia 5
DO - Repubblica Dominicana 5
DZ - Algeria 5
HN - Honduras 5
BA - Bosnia-Erzegovina 4
KZ - Kazakistan 4
PA - Panama 4
SC - Seychelles 4
AM - Armenia 3
BH - Bahrain 3
BS - Bahamas 3
LA - Repubblica Popolare Democratica del Laos 3
LB - Libano 3
LT - Lituania 3
LU - Lussemburgo 3
NZ - Nuova Zelanda 3
PR - Porto Rico 3
BB - Barbados 2
BW - Botswana 2
DM - Dominica 2
EE - Estonia 2
GA - Gabon 2
HT - Haiti 2
KW - Kuwait 2
MN - Mongolia 2
OM - Oman 2
PS - Palestinian Territory 2
QA - Qatar 2
Totale 45.601
Città #
Moscow 4.361
Dublin 2.124
Jacksonville 1.671
San Jose 1.528
Hong Kong 1.426
Santa Clara 1.393
Singapore 1.313
Chandler 1.022
Council Bluffs 851
Ashburn 835
Princeton 336
Ho Chi Minh City 324
Seoul 324
Roxbury 277
Beijing 263
Naples 221
Dallas 210
Milan 207
Hanoi 202
Rome 195
Medford 191
Bremen 172
Cambridge 167
Hefei 163
Caserta 156
Ann Arbor 151
Wilmington 150
New York 147
Woodbridge 138
Los Angeles 129
Boardman 127
Bengaluru 118
The Dalles 115
Aversa 106
Istanbul 103
San Mateo 79
São Paulo 78
Des Moines 74
Nanjing 61
Orem 58
Da Nang 57
Bari 54
Munich 53
Mountain View 46
Chicago 42
Pune 41
Atlanta 40
Houston 40
Norwalk 39
Redwood City 39
Turin 39
Frankfurt am Main 38
Memphis 37
Düsseldorf 35
Rio de Janeiro 35
Toronto 35
Jinan 34
Haiphong 32
Guangzhou 31
Palermo 30
Napoli 28
Bologna 27
Tianjin 27
Tokyo 27
Nanchang 26
Belo Horizonte 25
Catania 24
Helsinki 24
San Francisco 24
Brasília 23
Brussels 23
Montreal 23
Nuremberg 23
Venice 23
Afragola 22
Phoenix 22
Amsterdam 21
Auburn Hills 21
Denver 19
Hải Dương 19
Torino 19
Warsaw 19
Brooklyn 18
Salerno 18
Turku 18
Vienna 18
Boston 17
Chennai 17
London 17
Shanghai 17
Bến Tre 16
San José 16
Brescia 15
Florence 15
Mexico City 15
Miami 15
Padova 15
Tashkent 15
Verona 15
Johannesburg 14
Totale 23.163
Nome #
La riabilitazione cognitiva e psicosociale nei pazienti affetti da schizofrenia 1.210
Italian version of the "Specific Level of Functioning" 914
Cognitive Impairment after Post-Acute COVID-19 Infection: A Systematic Review of the Literature 296
Aspetti neuropsicofisiologici dei disturbi del comportamento alimentare: implicazioni per il trattamento 256
Big databases and biobanks for studying the links between CKD, cognitive impairment, and dementia 228
Training individualizzato delle abilità neuro cognitive e sociali (SSANIT) in pazienti psicotici cronici 221
Adult separation anxiety disorder: clinical characteristics and attachment styles 204
Cognitive impairment in CKD patients: a guidance document by the CONNECT network 200
EPA Guidance on treatment of cognitive impairment in schizophrenia 196
Cognitive deficits in psychotic disorders and their impact on social functioning 186
A feasibility, acceptability and validation study of the Italian Version of a new cognitive remediation program for psychotic patients - CIRCuiTS 184
'Simple schizophrenia': a controlled MRI and clinical/neuropsychological study 182
Autism rating scale (ARS) - Italian version 179
EPA guidance on assessment of negative symptoms in schizophrenia 178
Premorbid academic and social functioning in patients with schizophrenia and its associations with negative symptoms and cognition 177
Survival from coma induced by an intentional 36-g overdose of extended-release quetiapine 176
Abnormal Bodily Phenomena questionnaire - Italian version 176
Translational research on cognitive impairment in chronic kidney disease 173
Aetiopathological mechanisms of negative symptoms in schizophrenia 173
A multimodal DTI-fMRI investigation on illusions 170
A large European, multicenter, multinational validation study of the Brief Negative Symptom Scale 167
Psychosis as a disorder of consciousness: Electrophysiological evidence 165
Characterization of premorbid functioning during childhood in patients with deficit vs. non-deficit schizophrenia and in their healthy siblings 163
Towards Precision Medicine in Psychosis: Benefits and Challenges of Multimodal Multicenter Studies-PSYSCAN: Translating Neuroimaging Findings From Research into Clinical Practice 163
Effectiveness of a social cognition remediation intervention for patients with schizophrenia: a randomized-controlled study 163
Correlati neuropsicologici della remissione clinica nella schizofrenia 162
A psychophysiological investigation of emotional processing in subjects with panic disorder 161
Interview Versus Performance Assessment of Cognition as Predictors of Real-World Outcomes in a Large-Scale Cross-Sectional Study in Schizophrenia 160
Aspetti neuropsicologici dei disturbi del comportamento alimentare: implicazioni per il trattamento 160
Chemotherapy-related cognitive impairment and kidney dysfunction 158
Advances in the understanding of the pathophysiology of schizophrenia and bipolar disorder through induced pluripotent stem cell models 158
COMT Val158Met and BDNF C270T polymorphisms in schizophrenia: a case-control study 158
Acute Effects of Music Therapy in Subjects With Psychosis During Inpatient Treatment 157
Assessment of the role of cognitive control on monetary reward and loss anticipation: An electrophysiological study in subjects with schizophrenia 157
Assessment of de novo copy-number variations in Italian patients with schizophrenia: Detection of putative mutations involving regulatory enhancer elements 157
Abnormal bodily experiences detected by Abnormal Bodily Phenomena questionnaire are more frequent and severe in schizophrenia than in bipolar disorder with psychotic features 156
Anomalie dei potenziali evento-correlati durante l’ascolto dicotico nella schizofrenia 155
An EEG-based neuroimaging study of emotional processing in subjects with panic disorder 154
ANHEDONIA AND REAL-LIFE MOTIVATION IN PATIENTS WITH SCHIZOPHRENIA 153
Tecniche di neuroimaging ad alta risoluzione temporale nello studio della schizofrenia 152
Social skills and neurocognitive individualized training in schizophrenia: comparison with structured leisure activities 152
Cognitive deficits and community functioning in chronic schizophrenia 152
The implementation of cognitive remediation interventions in Campania 152
Abnormalities of early visual ERP components elicited by both illusory and control stimuli in chronic schizophrenia 151
Psychosocial functioning in remitted and non-remitted schizophrenic patients 151
The Brief Negative Symptom Scale (BNSS): Independent validation in a large sample of Italian patients with schizophrenia 151
Schizofrenia e disfunzioni della lateralizzazione emisferica: Risultati di uno studio sui potenziali evento-correlati registrati durante l'ascolto di toni monoaurali e dicotici 151
The Specific Level of Functioning Scale: Construct validity, internal consistency and factor structure in a large Italian sample of people with schizophrenia living in the community 150
Neurocognitive functioning in subjects with eating disorders: the influence of neuroactive steroids 150
The cortical generators of P3a and P3b: a LORETA study 150
Attention and context-updating processes in deficit and nondeficit schizophrenia: an ERP study 150
Attention/executive control systems hyperactivity in OCD 150
Avolition-Apathy and White Matter Connectivity in Schizophrenia: Reduced Fractional Anisotropy Between Amygdala and Insular Cortex 150
Avolition and microstructural brain abnormalities in Schizophrenia: Reduced fractional anisotropy in pathways connecting amygdala and insular cortex 150
Amisulpride and olanzapine followed by open-label treatment with clozapine in first-episode schizophrenia and schizophreniform disorder (OPTiMiSE): a three-phase switching study 150
Correlations between Negative Symptoms and Cognitive Deficits in Individuals at First Psychotic Episode or at High Risk of Psychosis: A Systematic Review 147
Abnormalities of hemispheric lateralization in schizophrenic patients: a study using event-related potentials 147
Lateralization patterns of verbal stimuli processing assessed by reaction time and event-related potentials in schizophrenic patients 147
Event-related potentials in schizophrenic patients: clinical and neurophysiological correlates 146
ABNORMALITIES OF HEMISPHERE ASYMMETRIES AND INTERHEMISPHERIC INTEGRATION IN SCHIZOPHRENIA 146
Academic and social functioning in early life epochs in schizophrenia patients and first-degree unaffected relatives 146
Patterns of structural MRI abnormalities in deficit and nondeficit schizophrenia 145
Modified nutritional counselling to increase motivation to treatment in anorexia nervosa. 145
ERP changes induced by antipsychotic drugs 145
Evidence-based medicine and electrophysiology in schizophrenia 144
[The importance of recent neuropsychological and neurophysiological studies for social psychiatry] 144
Neuropsychological slowness in obsessive-compulsive disorder: Is it limited to tests assessing executive functions? 144
External validation of the five domains of negative symptoms: Focus on cognition, functional capacity, and real-world functioning 143
A multivariate approach to investigate the associations of electrophysiological indices with schizophrenia clinical and functional outcome 143
EEG microstate duration and syntax in acute, medication-naïve, first-episode schizophrenia: A multi-center study 143
C-EEG brain mapping in DSM-III schizophrenics after acute and chronic haloperidol treatment 143
An individualized programme of cognitive and psychosocial intervention in psychotic patients 143
QEEG indices in the prediction of clinical response to psychotropic drugs 142
EPA guidance on treatment of negative symptoms in schizophrenia 142
Electrophysiological Correlates of Reward Anticipation in Subjects with Schizophrenia: An ERP Microstate Study 141
Social skills and neurocognitive individualized training in schizophrenia 141
Controllo esecutivo e ritmo alfa nei pazienti con disturbo ossessivo-compulsivo (DOC) 141
Perceived body shape distortions among eating disorders: preliminary evaluation of the behavioral indices of a modified emotional stroop test 141
Body image distortion in eating disorders: a functional magnetic resonance imaging (fMRI) study 140
Factors influencing the outcome of integrated therapy approach in schizophrenia: A narrative review of the literature 139
QEEG MAPPING CHANGES AFTER A SINGLE-DOSE AS PREDICTORS OF CLINICAL-RESPONSE TO HALOPERIDOL IN SCHIZOPHRENIA 139
Brain regions activated during an auditory discrimination task in bulimic patients: Low-resolution brain electromagnetic tomography applied to event-related potentials 139
Disfunzione dell’emisfero destro nel disturbo da attacchi di panico: uno studio di neuroimmagine ad alta risoluzione temporale 138
Autism Rating Scale: A New Tool for Characterizing the Schizophrenia Phenotype 138
Assessment of Negative Symptoms in Schizophrenia: From the Consensus Conference-Derived Scales to Remote Digital Phenotyping 136
Correlati neurofisiologici della risposta clinica ai neurolettici tipici in pazienti schizofrenici al primo episodio di malattia 136
Auditory P300 topography in deficit and non-deficit schizophrenia 136
ELECTROPHYSIOLOGICAL INDICES OF REWARD ANTICIPATION ABNORMALITIES IN SUBJECTS WITH SCHIZOPHRENIA 136
EEG-Based Measures in At-Risk Mental State and Early Stages of Schizophrenia: A Systematic Review 136
Characterization of antipsychotic drugs: ERP and LORETA findings 135
The Cognitive Assessment Interview (CAI): Association with neuropsychological scores and real-life functioning in a large sample of Italian subjects with schizophrenia 135
Insight in cognitive impairment assessed with the Cognitive Assessment Interview in a large sample of patients with schizophrenia 134
Ipercontrollo esecutivo nella sindrome ossessivo-compulsiva: indici neuropsicofisiologici 134
Contributions of psychopatology and cognitive impairment to social functioning in patients with schizophrenia 134
La Sindrome Ossessivo-Compulsiva in una prospettiva neuropsicologica 133
QEEG alpha 1 changes after a single dose of high-potency neuroleptics as a predictor of short-term response to treatment in schizophrenic patients 133
Body image distortion in bulimia nervosa: a high temporal resolution brain imaging study. 132
Cognitive functions and psychopathological dimensions in schizophrenia 131
Stili di attaccamento e funzioni cognitive in un gruppo di pazienti con disturbo del comportamento alimentare 131
Lateralizzazione emisferica ed eterogeneità legata al sesso nella schizofrenia 131
Totale 17.403
Categoria #
all - tutte 156.369
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 156.369


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2021/20221.936 0 0 0 79 765 15 39 53 84 95 142 664
2022/20233.893 406 135 42 304 421 289 16 208 1.900 31 63 78
2023/20241.814 152 70 135 157 574 137 49 76 26 35 140 263
2024/20255.977 79 81 100 300 836 834 883 422 786 946 365 345
2025/202621.580 814 1.055 969 973 1.714 11.616 1.273 933 814 658 487 274
2026/20273.268 205 857 1.660 546 0 0 0 0 0 0 0 0
Totale 46.353